147 related articles for article (PubMed ID: 9795048)
1. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
2. Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructures.
Wolf C; Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):187-96. PubMed ID: 9795053
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures].
Schulze FR; Alisch RA; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1994 Jul; 327(7):455-62. PubMed ID: 7915515
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacology of combined histamine H1-/H2-receptor antagonists containing diphenhydramine and cyproheptadine derivatives.
Wolf C; Schunack W
Arch Pharm (Weinheim); 1996 Feb; 329(2):87-94. PubMed ID: 8851472
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and dual histamine H₁ and H₂ receptor antagonist activity of cyanoguanidine derivatives.
Sadek B; Alisch R; Buschauer A; Elz S
Molecules; 2013 Nov; 18(11):14186-202. PubMed ID: 24248146
[TBL] [Abstract][Full Text] [Related]
6. Piperidine-containing histamine H3-receptor antagonists of the carbamate series: variation of the spacer length.
Łazewska D; Kieć-Kononowicz K; Pertz HH; Stark H; Schunack W; Elz S
Pharmazie; 2001 Dec; 56(12):927-32. PubMed ID: 11802653
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.
Buschauer A; Baumann G
Agents Actions Suppl; 1991; 33():231-56. PubMed ID: 1828931
[TBL] [Abstract][Full Text] [Related]
8. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
Buschauer A
J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
[TBL] [Abstract][Full Text] [Related]
10. Histamine analogues, XXXV: 2-substituted histamine derivatives containing classical moieties of H2-antagonists--a novel class of H1-agonists.
Zingel V; Elz S; Schunack W
Arch Pharm (Weinheim); 1993 Mar; 326(3):143-51. PubMed ID: 8097625
[TBL] [Abstract][Full Text] [Related]
11. EFFECTS OF HISTAMINE AND RELATED COMPOUNDS ON THE BOVINE IRIS DILATOR.
KAMEI CH
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):273-8. PubMed ID: 8803959
[TBL] [Abstract][Full Text] [Related]
12. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an accessory binding area in the histamine H2 receptor.
Orsetti M; Sorba G
Eur J Pharmacol; 1991 Jul; 207(3):259-65. PubMed ID: 1680063
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and pharmacological activity of fluorescent histamine H2 receptor antagonists related to potentidine.
Li L; Kracht J; Peng S; Bernhardt G; Elz S; Buschauer A
Bioorg Med Chem Lett; 2003 May; 13(10):1717-20. PubMed ID: 12729649
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and histamine H2-receptor activity of heterocyclic impromidine analogues.
Buschauer A; Lachenmayr F; Schunack W
Pharmazie; 1992 Feb; 47(2):86-91. PubMed ID: 1353262
[TBL] [Abstract][Full Text] [Related]
16. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
17. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
18. Potential histamine H2-receptor antagonists. 2. N-alpha-Guanylhistamine.
Durant GJ; Parsons ME; Black JW
J Med Chem; 1975 Aug; 18(8):830-3. PubMed ID: 240023
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity characterization of an H2-receptor antagonist, 3-amino-4-[4-[4-(1-piperidinomethyl)-2-pyridyloxy]-cis-2-++ +butenylamino]- 3-cyclobutene-1,2-dione hydrochloride (T-066), involved in the insurmountable antagonism against histamine-induced positive chronotropic action in guinea pig atria.
Kijima H; Isobe Y; Muramatsu M; Yokomori S; Suzuki M; Higuchi S
Biochem Pharmacol; 1998 Jan; 55(2):151-7. PubMed ID: 9448737
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
